Alerts will be sent to your verified email
Verify Email
ANUH PHARMA
|
Anuh Pharma
|
TTK Healthcare
|
Zota Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.67 % | 0.18 % | 0.09 % |
|
Financials
|
|||
|
5 yr Average ROE
|
13.45 % | 22.02 % | 2.89 % |
|
5yr average Equity Multiplier
|
1.7 | 1.58 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 1.15 | 1.02 |
|
5yr Avg Net Profit Margin
|
6.33 % | 22.14 % | 2.36 % |
|
Price to Book
|
4.83 | 2.25 | 12.62 |
|
P/E
|
22.81 | 33.71 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
32.8 Days | -41.8 Days | 76.98 Days |
|
Inventory Days
|
54.8 Days | 41.67 Days | 102.55 Days |
|
Days Receivable
|
105.71 Days | 36.67 Days | 83.71 Days |
|
Days Payable
|
116.48 Days | 102.9 Days | 81.11 Days |
|
5yr Average Interest Coverage Ratio
|
36.35 | 11.04 | 61.54 |
|
5yr Avg ROCE
|
18.44 % | 9.07 % | 5.03 % |
|
5yr Avg Operating Profit Margin
|
10.89 % | 7.68 % | 7.62 % |
|
5 yr average Debt to Equity
|
0.08 | 0.07 | 0.0 |
|
5yr CAGR Net Profit
|
9.13 % | 92.23 % | n/a |
|
5yr Average Return on Assets
|
8.09 % | 16.15 % | 2.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.92 % | 74.56 % | 66.15 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.28 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.55 % | 0.0 | -3.82 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -2.29 % | 0.0 |
|
Anuh Pharma
|
TTK Healthcare
|
Zota Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|
